Share of clinical development medicines dedicated to non-communicable diseases
Proportion of medicines in clinical development that target non-communicable diseases.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
1 record · 1 region · 2025
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Enabling innovation: The R&D ecosystem for medicines and vaccines | IFPMA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Share of clinical development medicines dedicated to non-communicable diseases. Retrieved from https://statorigin.org/indicators/share-of-clinical-development-medicines-dedicated-to-non-communicable-diseases